An Analysis of Recent FDA Oncology Scientific Publications

In addition to its primary regulatory role, the Office of Hematology and Oncology Products at the U.S. Food and Drug Administration (FDA) is engaged in many forms of scientific authorship. During the period of 2010 to 2018, FDA oncology staff contributed to 356 publications in the scientific literat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Schneider, Julie A., Miklos, Andrew C., Onken, James, Gong, Yutao, Calcagno, Anna Maria, Blumenthal, Gideon M., Aragon, Richard, Pazdur, Richard
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Regulatory Issues: FDA
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066718/
https://ncbi.nlm.nih.gov/pubmed/32162806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0503
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares